CSTF2T
Cleavage stimulation factor subunit 2 tau variant
Also known as: CstF-64T, CSTFT_HUMAN, DKFZp434C1013, KIAA0689, tauCstF-64
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H0L4
- Gene
- CSTF2T
- Ensembl
- ENSG00000177613
- Chromosome
- 10
- Canonical length
- 616 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Basal body
OverviewNCBI Gene
Enables RNA binding activity. Predicted to be involved in mRNA 3'-end processing. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
616 residues, UniProt reviewed canonical sequence.
>Q9H0L4|CSTF2T
1 MSSLAVRDPA MDRSLRSVFV GNIPYEATEE QLKDIFSEVG SVVSFRLVYD RETGKPKGYG
61 FCEYQDQETA LSAMRNLNGR EFSGRALRVD NAASEKNKEE LKSLGPAAPI IDSPYGDPID
121 PEDAPESITR AVASLPPEQM FELMKQMKLC VQNSHQEARN MLLQNPQLAY ALLQAQVVMR
181 IMDPEIALKI LHRKIHVTPL IPGKSQSVSV SGPGPGPGPG LCPGPNVLLN QQNPPAPQPQ
241 HLARRPVKDI PPLMQTPIQG GIPAPGPIPA AVPGAGPGSL TPGGAMQPQL GMPGVGPVPL
301 ERGQVQMSDP RAPIPRGPVT PGGLPPRGLL GDAPNDPRGG TLLSVTGEVE PRGYLGPPHQ
361 GPPMHHASGH DTRGPSSHEM RGGPLGDPRL LIGEPRGPMI DQRGLPMDGR GGRDSRAMET
421 RAMETEVLET RVMERRGMET CAMETRGMEA RGMDARGLEM RGPVPSSRGP MTGGIQGPGP
481 INIGAGGPPQ GPRQVPGISG VGNPGAGMQG TGIQGTGMQG AGIQGGGMQG AGIQGVSIQG
541 GGIQGGGIQG ASKQGGSQPS SFSPGQSQVT PQDQEKAALI MQVLQLTADQ IAMLPPEQRQ
601 SILILKEQIQ KSTGASLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSTF2T can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.62
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- tongue: 21 nTPM
- skeletal muscle: 21 nTPM
- thymus: 20 nTPM
- lymph node: 18 nTPM
- tonsil: 18 nTPM
- parathyroid gland: 17 nTPM
Single-cell type
- cardiomyocytes: 43 nCPM
- early primary spermatocytes: 37 nCPM
- cytotrophoblasts: 29 nCPM
- thymic myoid cells: 29 nCPM
- erythrocyte progenitors: 27 nCPM
- smooth muscle cells: 26 nCPM
Immune cell
- NK-cell: 11 nTPM
- MAIT T-cell: 4.9 nTPM
- T-reg: 4.6 nTPM
- eosinophil: 4.5 nTPM
- naive CD4 T-cell: 4.4 nTPM
- myeloid DC: 4.3 nTPM
Brain region
- white matter: 34 nTPM
- spinal cord: 26 nTPM
- cerebellum: 25 nTPM
- medulla oblongata: 25 nTPM
- pons: 25 nTPM
- basal ganglia: 24 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.61
- gnomAD pLI
- 0.09
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- Cleavage stimulation factor subunit 2, hinge domain
- Transcription termination and cleavage factor, C-terminal domain
- RNA-binding domain superfamily
- Transcription termination and cleavage factor, C-terminal domain superfamily
- RNA recognition motif
- Transcription termination and cleavage factor C-terminal
- Hinge domain of cleavage stimulation factor subunit 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CSTF2T in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSTF2T as an antibody target. Whether an autoantibody or antibody against CSTF2T could matter depends on whether native CSTF2T is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSTF2T is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSTF2T as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...